Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase

被引:45
作者
Augeri, DJ
O'Connor, SJ
Janowick, D
Szczepankiewicz, B
Sullivan, G
Larsen, J
Kalvin, D
Cohen, J
Devine, E
Zhang, HC
Cherian, S
Saeed, B
Ng, SC
Rosenberg, S
机构
[1] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Dept Combinatorial Chem, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm980298s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.
引用
收藏
页码:4288 / 4300
页数:13
相关论文
共 31 条
[11]   ALL RAS PROTEINS ARE POLYISOPRENYLATED BUT ONLY SOME ARE PALMITOYLATED [J].
HANCOCK, JF ;
MAGEE, AI ;
CHILDS, JE ;
MARSHALL, CJ .
CELL, 1989, 57 (07) :1167-1177
[12]   Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase [J].
Hunt, JT ;
Lee, VG ;
Leftheris, K ;
Seizinger, B ;
Carboni, J ;
Mabus, J ;
Ricca, C ;
Yan, N ;
Manne, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :353-358
[13]   BENZODIAZEPINE PEPTIDOMIMETICS - POTENT INHIBITORS OF RAS FARNESYLATION IN ANIMAL-CELLS [J].
JAMES, GL ;
GOLDSTEIN, JL ;
BROWN, MS ;
RAWSON, TE ;
SOMERS, TC ;
MCDOWELL, RS ;
CROWLEY, CW ;
LUCAS, BK ;
LEVINSON, AD ;
MARSTERS, JC .
SCIENCE, 1993, 260 (5116) :1937-1942
[14]   PROTEIN FARNESYLTRANSFERASE INHIBITORS BLOCK THE GROWTH OF RAS-DEPENDENT TUMORS IN NUDE-MICE [J].
KOHL, NE ;
WILSON, FR ;
MOSSER, SD ;
GIULIANI, E ;
DESOLMS, SJ ;
CONNER, MW ;
ANTHONY, NJ ;
HOLTZ, WJ ;
GOMEZ, RP ;
LEE, TJ ;
SMITH, RL ;
GRAHAM, SL ;
HARTMAN, GD ;
GIBBS, JB ;
OLIFF, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :9141-9145
[15]   Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity [J].
Leftheris, K ;
Kline, T ;
Vite, GD ;
Cho, YH ;
Bhide, RS ;
Patel, DV ;
Patel, MM ;
Schmidt, RJ ;
Weller, HN ;
Andahazy, ML ;
Carboni, JM ;
GulloBrown, JL ;
Lee, FYF ;
Ricca, C ;
Rose, WC ;
Yan, N ;
Barbacid, M ;
Hunt, JT ;
Meyers, CA ;
Seizinger, BR ;
Zahler, R ;
Manne, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :224-236
[16]   Ras farnesyltransferase: A new therapeutic target [J].
Leonard, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (19) :2971-2990
[17]   RAS CAAX PEPTIDOMIMETIC FTI-277 SELECTIVELY BLOCKS ONCOGENIC RAS SIGNALING BY INDUCING CYTOPLASMIC ACCUMULATION OF INACTIVE RAS-RAF COMPLEXES [J].
LERNER, EC ;
QIAN, YM ;
BLASKOVICH, MA ;
FOSSUM, RD ;
VOGT, A ;
SUN, JZ ;
COX, AD ;
DER, CJ ;
HAMILTON, AD ;
SEBTI, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26802-26806
[18]   Inhibitors of farnesyl protein transferase.: 4-amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine [J].
Mallams, AK ;
Rossman, RR ;
Doll, RJ ;
Girijavallabhan, VM ;
Ganguly, AK ;
Petrin, J ;
Wang, L ;
Patton, R ;
Bishop, WR ;
Carr, DM ;
Kirschmeier, P ;
Catino, JJ ;
Bryant, MS ;
Chen, KJ ;
Korfmacher, WA ;
Nardo, C ;
Wang, SY ;
Nomeir, AA ;
Lin, CC ;
Li, ZJ ;
Chen, JP ;
Lee, S ;
Dell, J ;
Lipari, P ;
Malkowski, M ;
Yaremko, B ;
King, I ;
Liu, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (06) :877-893
[19]   OXIDATION OF LONG-CHAIN AND RELATED ALCOHOLS TO CARBONYLS BY DIMETHYL-SULFOXIDE ACTIVATED BY OXALYL CHLORIDE [J].
MANCUSO, AJ ;
HUANG, SL ;
SWERN, D .
JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (12) :2480-2482
[20]   PALLADIUM-CATALYZED CROSS-COUPLING REACTIONS OF ORGANOBORON COMPOUNDS [J].
MIYAURA, N ;
SUZUKI, A .
CHEMICAL REVIEWS, 1995, 95 (07) :2457-2483